Journal ArticleDOI
Dystonic Camptocormia: Clinical Presentation, Diagnosis, and Treatment Results
Reads0
Chats0
TLDR
A phased and integrated approach was shown to be required for managing patients with camptocormia caused by dystonic hyperkinesis, and local botulinum toxin injections and deep brain stimulation are the most effective treatments.Abstract:
This study was aimed at assessing clinical features of camptocormia as one of the dystonia symptoms and evaluating the efficacy of various treatments for this condition. The study involved 39 patients with dystonia and camptocormia symptoms. We analyzed the clinical features of dystonic camptocormia and evaluated the results of pharmacotherapy and botulinum therapy as well as neuromodulation methods, namely transcranial magnetic stimulation and deep brain stimulation. A phased and integrated approach was shown to be required for managing patients with camptocormia caused by dystonic hyperkinesis. Local botulinum toxin injections and deep brain stimulation are the most effective treatments. More extensive use of low-frequency transcranial magnetic stimulation may be advisable for everyday practical use in patients with dystonic camptocormia.read more
References
More filters
Journal ArticleDOI
Phenomenology and classification of dystonia: a consensus update.
Alberto Albanese,Kailash P. Bhatia,Susan B. Bressman,Mahlon R. DeLong,Stanley Fahn,Victor S.C. Fung,Mark Hallett,Joseph Jankovic,Hyder A. Jinnah,Christine Klein,Anthony E. Lang,Jonathan W. Mink,Jan K. Teller +12 more
TL;DR: An international panel consisting of investigators with years of experience in this field that reviewed the definition and classification of dystonia provides a new general definition and proposes a new classification and encourages clinicians and researchers to use these innovative definitions and test them in the clinical setting on a variety of patients with Dystonia.
Journal ArticleDOI
EFNS guidelines on diagnosis and treatment of primary dystonias
Alberto Albanese,Friederich Asmus,Kailash P. Bhatia,Antonio E. Elia,Bulent Elibol,Graziella Filippini,Thomas Gasser,Joachim K. Krauss,Nardo Nardocci,Alistair Newton,Josep Valls-Solé +10 more
TL;DR: This document is intended to provide a revised version of earlier guidelines published in 2006, and is likely to be modified in the future to reflect the changing needs of the rapidly changing environment.
Journal ArticleDOI
Camptocormia: Pathogenesis, classification, and response to therapy
Shaheda N. Azher,Joseph Jankovic +1 more
TL;DR: Etiologic classification of camptocormia is proposed and it is concluded that this heterogeneous disorder has multiple etiologies and variable response to systemic and local therapies.
Journal ArticleDOI
Deep Brain Stimulation: Current and Future Clinical Applications
TL;DR: This review summarizes many of the current and potential future clinical applications of deep brain stimulation and indicates that a decrease in medication can be instrumental in reducing the disabling features of dyskinesias in patients with Parkinson disease.
Journal ArticleDOI
Parkinson’s disease with camptocormia
Frédéric Bloch,J. L. Houeto,S. Tezenas du Montcel,Fabrice Bonneville,Fabien Etchepare,M.-L. Welter,Sophie Rivaud-Péchoux,Valérie Hahn-Barma,Thierry Maisonobe,C. Béhar,J. Y. Lazennec,Ewa Kurys,Isabelle Arnulf,Anne-Marie Bonnet,Yves Agid +14 more
TL;DR: Patients with camptocormia were characterised by prominent levodopa-unresponsive axial symptoms (ie, axial rigidity, gait disorder and postural instability), along with a tendency for greater error in the antisaccade paradigm, and it is suggested that the salient features of parkinsonism observed in patients with camps are likely to represent a specific form of Parkinson’s disease.